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Abstract: The primary cause(s) of neuronal death in most cases of neurodegenerative 
diseases, including Alzheimer’s and Parkinson’s disease, are still unknown. However, the 
association of certain etiological factors, e.g., oxidative stress, protein misfolding/aggregation, 
redox metal accumulation and various types of damage to the genome, to pathological 
changes in the affected brain region(s) have been consistently observed. While redox metal 
toxicity received major attention in the last decade, its potential as a therapeutic target  
is still at a cross-roads, mostly because of the lack of mechanistic understanding of metal 
dyshomeostasis in affected neurons. Furthermore, previous studies have established the 
role of metals in causing genome damage, both directly and via the generation of reactive 
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oxygen species (ROS), but little was known about their impact on genome repair.  
Our recent studies demonstrated that excess levels of iron and copper observed in 
neurodegenerative disease-affected brain neurons could not only induce genome damage in 
neurons, but also affect their repair by oxidatively inhibiting NEIL DNA glycosylases, 
which initiate the repair of oxidized DNA bases. The inhibitory effect was reversed by  
a combination of metal chelators and reducing agents, which underscore the need for 
elucidating the molecular basis for the neuronal toxicity of metals in order to develop 
effective therapeutic approaches. In this review, we have focused on the oxidative genome 
damage repair pathway as a potential target for reducing pro-oxidant metal toxicity in 
neurological diseases. 
Keywords: redox transition metals; heavy metals; DNA base excision repair; metal toxicity; 
metal homeostasis; neurodegeneration; Alzheimer’s disease; Parkinson’s disease 
 
1. Introduction 
Metal ions, many of which are essential in trace amounts, were also the first toxins known to 
humans. Even the essential metals are toxic or could be fatal when present in excess. A common 
mechanism of toxicity caused by redox-active metals is via the generation of reactive oxygen species 
(ROS), which affect both DNA and proteins. 
While metals have been implicated in multiple pathologies, including cancer, neurotoxicity is 
believed to be their most common manifestation. Compelling evidence has etiologically linked abnormal 
brain metal accumulations with aging, as well as various neurological disorders, including Alzheimer’s 
disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), Wilson’s disease (WD) 
and stroke [1–4]. Furthermore, only a fraction of these metal-accumulation diseases can be sourced to 
dietary or occupational exposure [1,5–7], although the source, as well as precise mechanism(s) of the 
majority of metal accumulation conditions remain obscure. It is important to mention that unlike other 
toxic compounds, the increased metal ion level could impact the homeostasis of all metals in the cell  
or organ due to its charged state and the natural cellular response towards maintaining a tight  
charge balance. In spite of an extensive literature on individual metal toxicity, the impact of  
metal dyshomeostasis is not completely understood. 
Because of extensive genome damage observed in metal-associated diseases, a casual linkage was 
suggested between excessive cellular metal levels and genotoxicity. Subsequent studies established the 
role of heavy metals, such as lead (Pb), chromium (Cr), nickel (Ni), etc., in causing direct damage to 
DNA via cross-linking and interference with transcription and replication processes, enhancing 
mutagenesis. Other metals, including cadmium (Cd) and copper (Cu), were shown to hinder cell 
growth and promote apoptosis [8], although, the underlying mechanism is not clear. 
Interestingly, recent studies have implicated a reduced genome damage repair capacity in neurons 
of individuals afflicted with metal-accumulating neurodegenerative diseases [9–11], implicating the 
accumulation of pro-oxidant metals in enhanced levels of unrepaired oxidative DNA damage. This 
prompted us and other investigators to examine the effect of metals on DNA repair pathways and  
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to understand the interplay among these diverse etiologies in neuronal toxicity. Redox-active Cu and 
iron (Fe) not only induce genome damage, but also specifically inhibit key enzymes in the oxidative 
genome damage machinery by both altering their structure and reversibly oxidizing cysteine residues 
in these proteins. We propose that inhibition of DNA repair plays a critical role in affecting the 
survival of postmitotic neurons, with inherently limited capacity for genome maintenance, because of 
the absence of replication-coupled repair processes. Furthermore, the reversible nature of metals’ 
inhibitory effect on DNA repair could be exploited to restore repair using specific metal chelators with 
reducing activity. These studies, which were subsequently corroborated by others, provided a new 
paradigm in our understanding of metal genotoxicity in neurons. In this review, we discuss the current 
knowledge on DNA repair pathways in neurons, the role of both essential and toxic metals in blocking 
these processes and how the mechanistic understanding of the phenomenon could be exploited for 
efficient therapeutic interventions. 
2. Oxidative Insults and Repair in Human Genome 
Oxidative genome damage is an inevitable consequence of metabolism in aerobic organisms.  
ROS and reactive nitrogen species (RNS) are continuously produced during respiration [12] and also 
during the activation of cellular defense pathways [13]. The levels of these pro-oxidants, including free 
radicals, can be enhanced several fold upon exposure to external factors, like heavy metals, smoking, 
ionizing radiation and other genotoxic stress [14–16]. A balance between DNA damage and repair 
capacity exists in a healthy cell to efficiently repair an estimated 10
4
 oxidized base lesions and single-strand 
breaks (SSBs) that are generated by ROS daily in a mammalian cell’s genome [17,18]. In addition to 
ROS and RNS, accumulated transition metals (e.g., Fe, Cu, Cr, Cd and cobalt (Co)), most of which are 
redox-active, induce a plethora of toxic free radicals through their participation in various cellular 
oxidation-reduction reactions. In the presence of hydrogen peroxide, these Fe and Cu ions generate 
toxic hydroxyl radicals via a Fenton or Fenton-like reactions [19,20], as illustrated below. 
Fe(III) + O2
−
 ↔ Fe(II) + O2 
Fe(II) + H2O2 → Fe(III) + OH

 + OH
−
 (Fenton reaction) 
Cu(I) + H2O2 → Cu(II) + OH

 + OH
−
 
In addition, hydroxyl free radicals are also generated as a product of the Haber–Weiss reaction [21]. 
O2
−
 + H2O2 ↔ O2 + OH

 +OH−  
OH

 + H2O2 → H2O + H
+
 + O2
−
  
2.1. Types of Oxidative Damage in DNA 
Several dozens of oxidized base modifications, apurinic/apyrimidinic (AP) lesions, oxidized  
sugar fragments and SSBs with various blocked termini (Table 1) are induced by ROS in the human 
genome [22,23]. These, when unrepaired, have been implicated in various pathophysiological conditions. 
Common base lesions 5-hydroxyuracil (5-OHU), thymine glycol, 8-oxo-7,8-dihydroguanine (8-oxoG), 
2,6-diamino-4-hydroxy-5-formamidopyrimidine (Fapy-G) and 4,6-diamino-5-formamidopyrimidine 
(Fapy-A) have been identified in affected regions of the AD brain (Figure 1) [24,25]. Sugar oxidation 
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normally causes SSB formation in DNA [26,27], which is also formed as an intermediate during  
the repair of oxidized base lesions. The common ROS-induced SSBs include 3'-phosphoglycolate,  
3'-phosphate and 5'-deoxyribosephosphate blocked termini, whose processing is a critical step in the repair 
pathway [28,29]. 
Table 1. Human diseases associated with metal toxicity. While excessive metal ions have 
been linked to genomic instability in cancer, the major manifestation of metal toxicity is 
aging and age-related neurological diseases, implying the susceptibility of the CNS. 
Disease Linked Metal Toxicity References 
Alzheimer’s Disease Fe, Cu, Zn, Al [30–34] 
Parkinson’s Disease Fe, Zn, Al, Cu, Mn [1,10,34–40] 
Huntington’s Disease Cu, Fe [41–47] 
Wilson’s Disease Cu, Fe [48–51] 
Amyotrophic Lateral Sclerosis Fe, Cu [52,53] 
Friedreich’s Ataxia Fe, Cu, Zn [54–56] 
Xeroderma Pigmentosum Co, Cd, Ni [57–59] 
Cancer Fe, Pb, Cd, Ni, Hg, Co [20,60–65] 
Figure 1. ROS and RNS are constantly produced during aerobic metabolism. ROS generate 
several dozen oxidized base lesions and single-strand breaks (SSBs) in the genome. SSBs 
are also generated as intermediates during the processing of oxidized bases via base 
excision repair (BER). ROS-induced SSBs contain diverse termini, like 3'-phosphoglycolate, 
3'-phosphate, 5'-OH and 5'-deoxyribose phosphate. 
 
  
ROS/NOS and other free radicals
Oxidized base lesion
Guanine Cytosine Adenine Thymine
BER
Intermediates
SSB
5' HOOH
5' 3' dRP
5'
3' p
5' OH
5' OH 5' dRP
Biomolecules 2014, 4 682 
 
 
2.2. Repair of Oxidative Genome Damage: Basic Mechanism(s) and Complexity 
Most oxidized damage in the genome, including base lesions, AP sites and SSBs, are repaired via 
the base excision/single-strand break repair (BER/SSBR) pathway, which is highly versatile and 
evolutionarily conserved from bacteria to humans. In its simplistic form, BER involves four key 
reactions, namely: (i) recognition and excision of the base lesion by a DNA glycosylase and cleavage 
of the resulting AP site by the glycosylase itself (for oxidized base-specific bi-functional enzymes) in  
a sequential reaction or by AP endonuclease 1 (APE1) (for mono-functional glycosylases) in the 
following step; (ii) processing of the 5' and/or 3' blocked termini by specific SSB end cleaning 
enzymes to generate polymerase-compatible 5'-P/3'-OH ends; (iii) nucleotide gap filling by a DNA 
polymerase; and finally, (iv) DNA ligases (Lig III or I) seal the resulting nick to complete the  
repair process. 
Oxidized base-specific DNA glycosylases, discovered so far in humans, belong to two families, 
namely Nth and Nei. 8-oxoguanine DNA glycosylase-1 (OGG1) and NTH1 in the Nth family prefer 
oxidized purines and pyrimidines, respectively, from duplex DNA [66]. Recently discovered NEIL1 
and NEIL2, belonging to the Nei group [67–69], mostly prefer oxidized pyrimidine, both in duplex  
and single-stranded DNA, with a weaker activity with some purine lesions [70,71]. Recently 
characterized NEIL3, the fifth member of the Nei family [72], was shown to remove a broad spectrum 
of base lesions on single-stranded DNA with a preference for spiroiminodihydantoin (Sp) and 
guanidinohydantoin (Gh), which are the subsequent oxidation products of 8-oxoG [73,74]. Two types 
of 3'-non-ligatable termini are generated during the processing of oxidized bases by these glycosylases. 
OGG1 and NTH1 execute a β lyase reaction at the AP site yielding 3'-phospho-α,β-unsaturated 
aldehyde (3'-dRP) and 5'-P; on the other hand, NEILs catalyze βδ elimination, forming 3'-P and 5'-P 
groups [75]. APE1 and polynucleotide kinase 3'-phosphatase (PNKP) work downstream of glycosylases 
in the BER pathway, removing 3'-dRP and 3'-P, respectively. However, APE1 primarily processes AP 
sites generated by mono-functional glycosylases to produce strand breaks with 3'-OH and 5'-dRP ends. 
In mammalian cells, Polβ acts as a bi-functional enzyme, possessing both polymerase and 5'-dRP lyase 
activity, removing the dRP residue to generate 5'-OH terminus [76], in addition to incorporating the 
missing nucleotide at the 3'-OH. While Polβ predominantly participates in single nucleotide 
incorporation or short patch (SP- or SN-) BER, replicative DNA polymerase δ (Polδ)-mediated BER 
was identified to involve a repair patch size of 2–8 nucleotides in a long patch (LP) BER pathway. 
Flap endonuclease 1 (FEN-1) is required for such repair to cleave off the displaced flap structure [77,78]. 
Furthermore, although few studies have suggested the ability of Polβ to participate in LP-BER in vitro, 
in coordination with FEN-1, whether it occurs in vivo is unclear [79]. In the final repair step, LigI or 
LigIIIα complete the nick sealing process of the phosphodiester backbone. LigI primarily acts during 
DNA replication and during LP-BER [23,80]. Recently, LigIII was shown to be redundant for nuclear 
DNA repair, because LigI serves as proficient back up [81]. The LigI expression level is highest in 
proliferating cells and reduced levels are present in non-cycling cells, like neurons, indicating that 
LigIII cannot substitute for all of the LigI-related activities [82]. A unique feature of the mammalian 
BER/SSBR is that the interactions of the BER proteins are highly coordinated and play a crucial role in 
efficient repair [78,83]. 
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2.3. SSBR, a Variant of BER with Diverse End-Processing Reactions 
ROS-induced SSBs could involve several types of non-ligatable termini, in addition to the ones 
observed in BER, and thus, SSBR employs additional end-processing enzymes [23]. 3'-phosphoglycolate 
and 3'-phosphoglycolaldehyde in mammalian genomes are generally removed by APE1. Tyrosyl 
phosphodiesterase I (TDP1) cleaves tyrosine-linked 3'-P generated by abortive topoisomerase I (Top I) 
reaction to 3'-P at the strand break in the TDP1/DNA complex [84,85]. Here, PNKP plays a dual role 
by both processing 3'-P and adding phosphate to the 5'-OH end [86]. Aprataxin releases 5'-AMP to 
restore the 5'-P terminus [87,88]. Some 3'-non-ligatable termini could also be excised by the XRCC1/XPF 
nuclease complex, which has an essential role in the nucleotide excision repair (NER) pathway by 
incising the damage-containing DNA strand 3' to the lesion site. After the conventional 3'-OH/5'-P  
are generated, SSBR and BER follow the same gap filling and ligation reactions. Thus, although end 
processing is more diverse in SSBR than BER, they share the last two reaction steps and enzymes. 
2.4. Complexity of BER/SSBR Pathway 
Unlike in bacteria, BER/SSBR in human cells is highly complex, involving additional cellular 
proteins that regulate the cell cycle dependence of repair, genome region-specific repair sub-pathways 
and in several back-up pathways [77,89]. These include accessary proteins XRCC1, PARP-1  
and -2, and non-canonical proteins hnRNP-U, YB1, etc. [23,75,89–97]. Furthermore, post-translational 
modifications in one or more components, including acetylation [98–101], phosphorylation [102–104], 
ubiquitylation [105–107], SUMOylation [108–110], methylation [111,112] and PARylation [113–115], 
regulate the repair process and rate in various cellular states. While a detailed account of specific 
modifications in BER/SSBR machinery is beyond the scope of this review, recent studies linking 
defects in acetylases/deacetylases with dramatic BER/SSBR deficiency and mutagenicity highlight the 
importance of such modifications in repair [101,116,117]. 
The presence of non-conserved, mostly disordered terminal peptide segments in early BER/SSBR 
proteins, as comprehensively reviewed in our previous review [23,118], could be critical for key functions, 
including damage sensing, protein-protein interactions, repair regulation via posttranslational modifications 
and nuclear localization signal (NLS) [118]. We believe that mammalian early BER enzymes, like 
NEIL1 or APE1, could be considered as ―hub‖ proteins with multiple interacting partners (>10), most 
of which utilize terminal disordered segment as common interaction interface [23,118,119]. 
2.5. Mitochondrial (Mt) BER/SSBR 
MtDNA is highly susceptible to oxidative stress because of its close proximity to the site of ROS 
generation and lack of protective histones [120,121]. The proteins involved in mtBER are encoded by  
the nuclear genome, many of which are identical to their nuclear counterparts, but few distinct 
mitochondrial specific isoforms exist. LigIII exists in distinct nuclear and mitochondrial isoforms,  
but only nuclear LigIIIα works in complex with the scaffold protein, XRCC1, in vivo [80,122]. 
Mitochondria have only one DNA polymerase (Polγ), which participates in both mtDNA replication 
and repair [123]. The high lipid content of mitochondrial membranes facilitates the accumulation of 
alkylating agents [124] and cationic metals, such as Cd, mercury (Hg), Pb, manganese (Mn), Fe and  
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Cu [125–127]. Furthermore, as would be expected, a higher mitochondrial BER capacity is observed in 
brain than other tissue types [128,129]. 
3. Current Understanding of BER/SSBR in the Central Nervous System (CNS) 
The CNS consists of the brain and spinal cord with multiple cell types, including neuron and glial 
cells. The major bottleneck for DNA repair in neuronal cells is that these cells are terminally 
differentiated and lack replication-associated repair [4]. Regulation of BER in neurons in various 
pathophysiological conditions is largely unknown [130]. During neuronal maturation, a decreased 
OGG1 level and increased NEIL1 and NEIL2 levels have been observed in rat brain [131]. It has been 
suggested that both NEIL1 and NEIL2 might have a potential role in maintaining the integrity of 
transcribed genes in terminally differentiated neurons. Studies demonstrating impaired memory 
retention in mice lacking NEIL1 further support the critical role of this enzyme in brain cells [132]. 
Besides protecting the genome from the accumulation of cytotoxic base lesions, the distribution and 
activity of NEIL3 in brain direct its specific role in stem cell differentiation [133,134]. NEIL3 is 
required for maintaining DNA integrity in neural progenitor cells, both during development and in 
adult brain [135]. NEIL3
−/−
 mice showed memory defects, coupled with the impaired proliferative 
capacity of hippocampal neural stem/progenitor cells, which is also correlated to reduced DNA repair 
capacity. Further, NEIL3-deficient neural progenitor cells were highly susceptible to oxidative  
stress [136]. Another glycosylase, specific for alkylated bases, MPG expresses strongly in cerebral 
cortex, cerebellum and hippocampus in brain [137]. Although, OGG1’s activity was found to be low in 
brain, NTH1 showed comparable expression and activity in brain, testes, kidney and liver. There are 
conflicting reports on brain OGG1 levels in ageing and neurological disorders: while a decreased 
OGG1 activity was observed in aged rat brain [138], its level was shown to increase in substantia nigra 
in PD [139]. Interestingly, a recent study suggested 8-oxoG repair via MUTYH-mediated BER (MUTYH 
excises A mispaired with 8-oxoG) rather than OGG1-mediated BER of the 8-oxoG-C pair. Consistently, 
mice lacking MUTYH were resistant to neurodegeneration, while mice lacking OGG1 or MTH1  
(an enzyme that depletes 8-oxoGTP from the pool) exhibited severe striatal neurodegeneration [140]. 
These findings suggest that MUTYH-mediated 8-oxoG repair may promote neurodegeneration. Both 
PNKP and APE1 are highly expressed in brain. The neuroprotective role of APE1 in the survival of 
oxidative stress-induced post-mitotic neurons has been well established [141–143]. The interaction of 
PNKP with scaffold protein XRCC1 has been shown to be crucial for efficient BER processing during 
oxidative stress [144]. Polβ, the major DNA polymerase in non-cycling neurons, is ubiquitously 
expressed in all brain regions [145], and its level decreases in an age-dependent manner. Other DNA  
replication-associated repair proteins’, like FEN-1, Pol δ/ε, PCNA and LigI, levels have been observed  
to be low in the adult brain, as expected, while XRCC1 and LigIIIα levels are high with respect to 
other tissue types [146]. These studies indicate that SN-BER might be the major BER pathway with a 
reduced level of LP-BER in matured neurons [147,148]. 
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4. Revisiting Metal Toxicity Diseases 
4.1. Metal Accumulation in CNS Etiologically Linked to Neurological Diseases 
Metals, such as Fe, Zn, Cu, Se, Mn, Mo, Co, Na and K, and other elements, like S, P, I, F, etc., are 
indispensable for life, because of their essential role in fundamental life functions. These are beneficial 
at a lower (optimum) concentration, but are toxic at a higher concentration. Most metals enter the brain 
through the ―blood brain barrier‖ (BBB) using specific carrier proteins. 
While the metal content is tightly regulated in normal brain, by being sequestered with storage 
proteins, e.g., ferritin, transferrin and ceruloplasmin, and released only in response to metabolic need, 
metal dyshomeostasis leading to the abnormal overload of free metal ions is a common feature in the 
pathogenesis of most, if not all, neurodegenerative diseases and aging. Specifically, accumulations of 
Fe, Cu, Al, Mn, etc. (either individually or together), is implicated in AD, PD, ALS, hereditary 
ferritinopathy and WD [48,149–153]. 
4.1.1. Essential Transition Metals 
Fe, Cu and Zn: The redox states of Fe(II/III) and Cu(I/II) that make them biologically important 
also make them toxic, due to the production of ROS. While most of the Fe in a healthy human body  
is present in hemoglobin, along with Cu and Zn, it serves as essential co-factors for a multitude of 
enzymes and signaling molecules and, thus, regulates various biological pathways, including 
mitochondrial energy production, DNA replication/transcription, synthesis of neurotransmitters, etc.  
In the normal brain, the major fraction of bio-available Fe and Cu (~70%) are typically sequestered in 
ferritin/transferrin and ceruloplasmin, respectively [154,155]. Studies have implicated Cu, Fe and Zn 
as key factors in the pathophysiology of AD and PD [156,157]. High levels of Cu (400 μM) and Zn  
(1 mM) were found in amyloid plaques and AD neuropil regions in comparison to healthy brain  
(70 μM Cu and 350 μM Zn) [32,158], which accumulate progressively during the transition from 
moderate to severe AD [156]. Furthermore, the injection of FeCl3 into the substantia nigra of adult rats 
resulted in a substantial selective decrease of striatal dopamine (95%), leading to PD-like symptoms [159]. 
Mn is another essential transition metal, ubiquitous in human cells in trace levels, primarily acting as a 
cofactor of mitochondria-specific SOD. Exposure of mice to a high Mn level causes a clinical disease 
characterized by extrapyramidal symptom resembling idiopathic PD (IPD) [160]. Further, the ability  
of Mn to enhance α-synuclein and amyloid-β misfolding/aggregation coupled with its abnormal 
distribution in brain suggests that Mn toxicity could contribute to AD, Huntington disease and ALS. 
4.1.2. Non-Essential Heavy Metals’ Impact on Human Health 
Al, an abundant element in the environment, is used in industry, medicine, food, water processing 
and agriculture. The average uptake of Al(III) ranges from 2.5 to 13 mg/day, depending on the food 
and cooking practice of country. Although, consistently implicated in the pathogenesis of AD, for the 
better part of the last century, the definite etiology of Al toxicity in AD has remained unknown. Al has 
never been demonstrated to have any definite biological function, but many studies have brought to 
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light its potential neurotoxicity in experimental animal models and in humans [161–163]. A detailed 
role of Al in neurodegenerative diseases was reviewed elsewhere [164]. 
Pb and Hg: Pb(II/IV) is a well-known neurotoxicant in children. The predominant route of exposure 
is through the ingestion of contaminated food, although Pd-based paint and contaminated water also 
contribute. Pb exposure has been linked with reduced IQ and behavior in children. It is considered to 
be a risk factor in accelerated cognitive decline, AD and PD [165]. Rodent studies suggest a reduction 
in the number of dopamine neurons and significant alterations in the nigrostriatal dopamine system 
after being exposed to Pb, which is consistent with PD pathology [166]. Pb also increases the 
expression of APP mRNA and elevated amyloid beta aggregation [167]. Primates exposed to Pb 
showed increased amyloidogenesis and senile plaque formation, both studies consistent with what is 
observed in AD brain samples [168]. 
Hg, another heavy metal, is highly neurotoxic, particularly when converted into methyl-Hg.  
This, commonly ingested via contaminated fish, passes through the BBB by binding to cysteine.  
Hg(II) exposure in humans causes PD-like pathology, including movement dysfunction, tremors and 
polyneuropathy. Mice exposed to methyl-Hg exhibit reduced neuritis of dopaminergic neurons and  
a reduction of striatal dopamine [169]. Finally, Hg and Pb could also generate ROS via lipid 
peroxidation, mitochondrial damage and superoxide production [170]. 
4.2. Complex Nature of Metal Toxicity in Neurodegenerative Diseases 
4.2.1. Environmental/Occupational Exposure versus Internal Redistribution 
While occupational or environmental exposure to metals predisposes humans to neurological 
dysfunction, as expected, these constitute only a small fraction of human neurodegenerative diseases. 
The majority of patients showing a marked increase in the levels of various metals in brain have no 
known metal exposure or increased dietary intake. Interestingly, we demonstrated that metal levels in 
blood and brain are inversely correlated in AD and PD [171,172], indicating metal redistribution from 
blood to brain or CSF, but the mechanism is unclear. We proposed that such an increased metal uptake 
in the brain may be driven by a toxic misfolded (amyloid) protein response. Most metals promote 
amyloid protein aggregation. This makes the highly toxic misfolded amyloid proteins inert initially, 
but when the aggregate level increases beyond a cells’ threshold, it would aggravate the neurotoxicity. 
4.2.2. Transition Metals’ Charge-Dependent Changes with Disease Progression 
Remarkably, studies also revealed that transition metals in their divalent states (e.g., Fe(II) or 
Cu(II)) increase in the early phase of AD, while trivalent forms (Fe(III) tend to increase in the later 
phase of the AD-affected brain [172]. Furthermore, an increase in trivalent metals forms in late-stage 
AD is accompanied with decrease in mono- or di-valent metals. Thus, the overall brain metal burden is 
never dramatically increased in AD; instead there is the abnormal redistribution of specific metals in 
different organs. In general, it appears that a common trait in many processes underlying neurodegeneration 
is a (direct or indirect) perturbation in the homeostasis of Cu, Zn, Fe, Al, etc. This could be important 
for formulating metal chelation therapy, which should consider supplementing the depleted metal, in 
addition to chelating the increased metal ions. 
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4.3. Metal Toxicity as Homeostatic Imbalance: A New Perspective 
There is a limited database on trace metal homeostasis in brain. Although several reports are 
available on individual metal level changes/distribution, no studies have successfully correlated  
the inter-elemental relationships. Our limited previous studies provided new information on the  
metal-homeostasis pattern in the brain and serum samples of AD/PD patients [1,173]. Due to the tight 
regulation of charge balance in a cell and across the membrane, the effect of changes in the level of  
a particular metal is not restricted to that metal alone, but instead, it would impact many other metals 
in that particular organ and, eventually, lead to metal dyshomeostasis and cellular dysfunction.  
This information is novel, but needs substantial database development to compute a model reflecting 
the total trace elemental homeostasis in human brain. We feel that such a database will be of great 
significance, not only for the early diagnosis of neurodegenerative and neuro-psychiatric disorders, but 
also in understanding these disorders using elemental homeostasis as a model system. Although 
numerous hypotheses have been proposed for the involvement of metals in various neurological 
dysfunctions (reviewed in [7,174]), conclusive evidence still remains vague, presumably due to the 
complex and dynamic nature of metal levels and toxicity. Hence, there is a need for a methodology to 
map not only trace element levels, but also to establish metal-metal-dependent-interrelationships in 
human brain with relevance to progressive metal accumulation diseases. 
5. Metals Induce Genome Damage, Both Directly and Circuitously 
Metal toxicity-linked conditions, including most neurological disorders, are commonly associated 
with extensive genome damage, particularly oxidative base damage and strand breaks [175], which 
suggest a causal link between the two phenomenon. Redox cycling Fe and Cu generate ROS via the 
Fenton reaction producing hydroxyl and superoxide radicals that further damage DNA. These metals 
can also produce DNA damage by their directly binding and nicking activity [176]. Other heavy 
metals, like Pb, Cd, etc., and Al also indirectly promote ROS/RNS generation by their high affinity 
binding to thiol groups containing enzymes and proteins [177,178], which are responsible for normal 
cellular defense mechanism against oxidative stress. Furthermore, while ROS and/or metals induce 
various oxidative modifications in DNA bases and SSBs, the accumulation of closely-spaced SSBs  
in non-cycling neurons could lead to secondary DSBs, which are the most toxic type of DNA genome 
damage [179]. 
6. Inhibition of DNA Repair by Redox Metals: A Double Whammy 
6.1. Pro-Oxidant Metals Inhibit BER Pathways 
While a significant decrease in genome repair capacity, including BER in neurons, has been 
observed in neurodegenerative diseases, as well as during ageing [180–183], the molecular events 
leading to such deficiency have not been characterized. A lack of a direct correlation between repair 
deficiencies with the expression of repair enzymes suggests the involvement of additional mechanisms. 
Repair defects involving heavy metal exposure were attributed to direct DNA binding, which not only 
induce DNA strand breaks, but also interfere with damage scanning and the recruitment of repair 
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machinery [184,185]. However, repair defects in most cases of sporadic neurodegenerative diseases 
that involve the dyshomeostasis of essential transition metals, such as Cu and Fe, were not characterized 
until recently, when we demonstrated that Cu and Fe specifically inhibit the activities of NEIL1 and 
NEIL2 by forming stable complexes with these proteins [9]. We showed that Fe(II/III) and Cu(II)  
at nanomolar (nM) to low micromolar (µM) levels inhibit NEILs’ activity with various base  
lesion-containing DNA substrates in vitro. The inhibition was found to be very specific, as demonstrated 
by the lack of a similar inhibition of OGG1 with 8-oxoG substrates. This also suggested that in 
contrast to the previously suspected mechanism, the inhibition is due to metal binding to NEILs rather 
than to DNA. The binding involved both hydrophobic and electrostatic forces, as indicated by the large 
negative enthalpy. In cell inhibition of NEILs by these metals was also observed based on the reduced 
repair activity of NEILs in extracts from SH-SY5Y neuroblastoma cells treated with FeSO4 or CuCl2. 
6.2. Mechanism of Repair Inhibition: Oxidation of Cysteines in NEIL DNA Glycosylases 
Partial reversal of Cu-mediated NEIL1 inhibition by a Cu-chelator, but nearly complete reversal, by 
a combination of a Cu-chelator, plus a reducing agent or curcumin with dual metal chelation, as well as 
reducing properties, suggested that NEIL1 inhibition by Cu involves the reversible oxidation of 
cysteine residues [9]. Furthermore, the CD spectra of the NEIL1-Cu complex showed a small, but 
clear, change in the secondary structure of NEIL1, which could cause the inhibition of its activity. 
Interestingly, although both Cu(II) and Fe(II) bind to NEIL1 and NEIL2, the secondary structure of 
NEIL2, unlike NEIL1, is not affected significantly. Given the presence of a zinc finger motif in 
NEIL2, but not in NEIL1, Cu(II) or Fe(II) may competitively replace the intrinsic Zn ion in NEIL2 and 
compromise its folding. 
Further, metal ions also disrupt protein-protein interactions during BER. DNA damage repair involves a 
highly coordinated signaling pathway that depends on appropriate protein-protein interactions during 
the signal transduction. We showed that Fe(II) affects NEIL1’s interaction with Polβ and FEN-1, 
which is critical for overall BER [9]. Thus, unlike previous studies that suggested that the inhibition of 
BER repair by metals may be due to their direct binding to DNA, these studies demonstrate a direct 
binding of redox metals with specific BER proteins, which affect their structure, as well as activities. 
6.3. Summary of Metal Toxicity Impact on Other DNA Repair Enzymes/Pathways 
In addition to NEILs, metal ions also inhibit other components of the DNA repair machinery  
(Table 2). It was observed that ~60% of LigIIIα activity was inhibited by FeCl3 (10–250 μM), which 
also affects Polβ [11]. The divalent ions, Cd2+, Ni2+ and Zn2+, inhibit the activity of recombinant 
human N-methylpurine-DNA glycosylase (MPG), a monofunctional DNA glycosylase, which removes 
a variety of alkylated bases [186,187]. Whiteside et al. showed that Cd and Cu inhibit phosphatase and 
kinase activities of both recombinant PNKP and its activity in human cell extracts [188]. Heavy metals 
could delay SSB rejoining in mammalian cells. Further, elevated Fe levels caused a reduction in FEN-1 
and LigIII activities, due to the interference of repair protein binding to their DNA substrates [9]. 
Thus, metal mediated genotoxicity could involve the induction of oxidative genome damage via:  
(i) free radical generation; and (ii) direct DNA binding; and inhibition of DNA repair via (i) inhibition 
of key BER/SSBR enzymes; and (ii) inhibiting interactions among repair proteins. Taken together, 
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these studies showed that excessive Fe/Cu and other pro-oxidant metals in neurodegenerative brains 
act as a ―double whammy‖ by inducing ROS that damage the genome and also by inhibiting damage 
repair at the same time (Figure 2). 
Table 2. Key genome repair enzymes affected by metals. Transition and heavy metals have 
been shown to inhibit the repair activities of key proteins involved in the BER, single-strand 
break repair (SSBR) and DSBR pathways. 
Repair Protein Affected by Metal(s) Repair Pathway Inhibiting Metal References 
NEIL1 BER Fe, Cu [9,175] 
NEIL2 BER Fe, Cu [9,175] 
APE1 BER/SSBR Fe, Cd, Pb [189] 
PNKP BER/SSBR/DSBR Cd, Cu [188] 
FEN-1 BER/SSBR/DSBR Fe [11] 
LigIII BER/SSBR/DSBR Fe [11] 
MPG BER Cd, Ni, Zn [186,187] 
Figure 2. The genotoxicity of metals in neuronal cells: a ―double-whammy‖. Excess 
accumulation of metals in neurons not only causes increased oxidative damage to the 
genome, both directly and via ROS, but also inhibits the repair of such damage by 
binding/oxidizing certain repair proteins. This creates an imbalance between genome 
damage and repair, and the resulting persistent accumulation of damage contributes to 
neuronal dysfunction and cell death.  
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7. Conclusions and Future Perspectives 
Molecular Understanding of the Complex, Multi-Targeted Nature of Metal Toxicity Is Important for 
Intervention Strategies 
Despite an enormous increase in our understanding of the neuropathological events in aging and in 
~200 types of neurological conditions, there is no cure available; current treatments slow progressive 
dementia only temporarily. This underscores the necessity of an overarching approach to explore 
newer strategies to unravel the mechanism of initiation/progression of neurodegeneration and to find 
more effective ways to prevent its onset, delay the progression and then effectively treat the disease to 
improve the quality of life for patients and their caregivers. Furthermore, despite multiple studies 
providing compelling evidence linking the misfolding/oligomerization of Aβ/tau, the build-up of Fe/Cu 
and other metals, the accumulation of genomic damage in the brain, how the interplay among these 
factors triggers neuronal apoptosis is still unclear. The role of metals as the key mediators of AD 
pathology has been reinforced by the fact that metal-chelation therapy has turned out to be promising 
in animal models of AD, although challenges regarding chelator choice and/or dosage together with 
the side effects of their sequestration of essential metals persist [9,190]. Our studies demonstrating that 
Fe/Cu acts as a ―double whammy‖ by inducing genome damage and also inhibiting its repair provided 
a molecular basis, whereby Cu reduces cysteine residues in NEILs, which could be reversed by a Cu 
chelator in combination with a reducing agent or curcumin, which has both chelating and reducing 
properties. In addition, other compounds/drugs, particularly of natural/plant origin with antioxidant/free 
radical scavenging, as well as metal chelation activities, should be looked into for their neuroprotective 
functions [191]. For example, melatonin, which possesses both antioxidant and metal chelation 
properties, has been demonstrated to reduce metal-induced toxicity in cells [192]. However, the 
protective role of melatonin in preventing metal-induced DNA repair inhibition still needs to be 
investigated. In view of melatonin’s ability to stimulate antioxidant enzymes, in addition to free radical 
scavenging and metal chelation, it will be interesting to examine a combination of melatonin and 
curcumin for preventing multimodal metal toxicity conditions. These results suggested that it is 
important to comprehensively understand the metal levels in a given case; characterizing the complete 
metal homeostasis and specific toxicity of the metals involved, including their role in genome 
damage/repair systems is required in order to develop an effective therapy [191]. This underscores the 
need to re-examine the role of metal toxicity in neurological diseases as a part of a therapeutic strategy 
in light of the new information of the human genome and its functions. 
Acknowledgments 
The research in the authors’ laboratories is supported by grants from the Alzheimer’s Association 
(NIRG-12-12-242135; Muralidhar L. Hegde), the Muscular Dystrophy Association (MDA294842; 
Muralidhar L. Hegde), the Houston Methodist Research Institute (Muralidhar L. Hegde), USPHS  
(R01 CA158910 and P01 CA92584; Sankar Mitra; R01 ES018948 and R01 AI062885; Istvan Boldogh), 
the Melo Brain Grant (Muralidhar L. Hegde and Kosagi Sharaf Rao), and SNI of SENACYT-Panama 
for doctoral fellowship (Erika Guerrero). Erika Guerrero We thank Sanjay Adhikari, Shiladitya 
Sengupta, Chunying Yang and Arijit Dutta for various discussions. This review with a limited focus on 
Biomolecules 2014, 4 691 
 
 
the impact of metal toxicity on genome damage and repair is not intended to provide a comprehensive 
literature on the topic, and hence, many appropriate citations may not be included, for which we 
sincerely apologize. 
Author Contributions 
Joy Mitra and Erika Guerrero prepared the first draft of the manuscript with assistance from  
Pavana Hegde and Haibo Wang, who also contributed in preparing the specific sections. Istvan Boldogh, 
Kosagi Rao and Sankar Mitra provided expert insights and edited the manuscript. Muralidhar Hegde 
directed the project, and prepared the final manuscript. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Hegde, M.L.; Shanmugavelu, P.; Vengamma, B.; Rao, T.S.; Menon, R.B.; Rao, R.V.; Rao, K.S. 
Serum trace element levels and the complexity of inter-element relations in patients with 
parkinson’s disease. J. Trace Elem. Med. Biol. 2004, 18, 163–171. 
2. Faller, P.; Hureau, C.; Berthoumieu, O. Role of metal ions in the self-assembly of the 
Alzheimer’s amyloid-beta peptide. Inorg. Chem. 2013, 52, 12193–12206. 
3. Stork, C.J.; Li, Y.V. Rising zinc: A significant cause of ischemic neuronal death in the CA1 
region of rat hippocampus. J. Cereb. Blood Flow Metab. 2009, 29, 1399–1408. 
4. Hanawalt, P.C. Emerging links between premature ageing and defective DNA repair.  
Mech. Ageing Dev. 2008, 129, 503–505. 
5. Tchounwou, P.B.; Yedjou, C.G., Patlolla, A.K.; Sutton, D.J. Heavy metal toxicity and the 
environment. Mol. Clin. Environ. Toxicol. 2012, 101, 133–164. 
6. Hartmann, A.; Speit, G. Effect of arsenic and cadmium on the persistence of mutagen-induced 
DNA lesions in human cells. Environ. Mol. Mutagen. 1996, 27, 98–104. 
7. Hegde, M.L.; Bharathi, P.; Suram, A.; Venugopal, C.; Jagannathan, R.; Poddar, P.; Srinivas, P.; 
Sambamurti, K.; Rao, K.J.; Scancar, J.; et al. Challenges associated with metal chelation therapy 
in Alzheimer’s disease. J. Alzheimers Dis. 2009, 17, 457–468. 
8. Kim, S.; Cheon, H.S.; Kim, S.Y.; Juhnn, Y.S.; Kim, Y.Y. Cadmium induces neuronal cell  
death through reactive oxygen species activated by GADD153. BMC Cell Biol. 2013, 
doi:10.1186/1471-2121-14-4. 
9. Hegde, M.L.; Hegde, P.M.; Holthauzen, L.M.; Hazra, T.K.; Rao, K.S.; Mitra, S. Specific inhibition 
of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: Potential 
etiological linkage to neurodegenerative diseases. J. Biol. Chem. 2010, 285, 28812–28825. 
10. Zatta, P.; Lucchini, R.; van Rensburg, S.J.; Taylor, A. The role of metals in neurodegenerative 
processes: Aluminum, manganese, and zinc. Brain Res. Bull. 2003, 62, 15–28. 
Biomolecules 2014, 4 692 
 
 
11. Li, H.; Swiercz, R.; Englander, E.W. Elevated metals compromise repair of oxidative DNA 
damage via the base excision repair pathway: Implications of pathologic iron overload in the 
brain on integrity of neuronal DNA. J. Neurochem. 2009, 110, 1774–1783. 
12. Breen, A.P.; Murphy, J.A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 1995, 
18, 1033–1077. 
13. Janssen, Y.M.; van Houten, B.; Borm, P.J.; Mossman, B.T. Cell and tissue responses to oxidative 
damage. Lab. Investig. 1993, 69, 261–274. 
14. Church, D.F.; Pryor, W.A. Free-radical chemistry of cigarette smoke and its toxicological 
implications. Environ. Health Perspect. 1985, 64, 111–126. 
15. Comhair, S.A.; Thomassen, M.J.; Erzurum, S.C. Differential induction of extracellular 
glutathione peroxidase and nitric oxide synthase 2 in airways of healthy individuals exposed to 
100% O2 or cigarette smoke. Am. J. Respir. Cell Mol. Biol. 2000, 23, 350–354. 
16. Narayanan, P.K.; Goodwin, E.H.; Lehnert, B.E. Alpha particles initiate biological production of 
superoxide anions and hydrogen peroxide in human cells. Cancer Res. 1997, 57, 3963–3971. 
17. Friedberg, E.C.; Walker, G.C.; Siede, W.; Wood, R.D.; Schultz, R.A.; Ellenberger, T. DNA Repair 
and Mutagenesis, 2nd ed.; ASM Press: Washington, DC, USA, 2006. 
18. Pardo, B.; Gomez-Gonzalez, B.; Aguilera, A. DNA repair in mammalian cells: DNA double-strand 
break repair: How to fix a broken relationship. Cell. Mol. Life Sci. 2009, 66, 1039–1056. 
19. Lloyd, R.V.; Hanna, P.M.; Mason, R.P. The origin of the hydroxyl radical oxygen in the fenton 
reaction. Free Radic. Biol. Med. 1997, 22, 885–888. 
20. Toyokuni, S. Iron and carcinogenesis: From fenton reaction to target genes. Redox Rep. 2002, 7, 
189–197. 
21. Valko, M.; Izakovic, M.; Mazur, M.; Rhodes, C.J.; Telser, J. Role of oxygen radicals in DNA 
damage and cancer incidence. Mol. Cell. Biochem. 2004, 266, 37–56. 
22. Mitra, S.; Izumi, T.; Boldogh, I.; Bhakat, K.K.; Hill, J.W.; Hazra, T.K. Choreography of 
oxidative damage repair in mammalian genomes. Free Radic. Biol. Med. 2002, 33, 15–28. 
23. Hegde, M.L.; Hazra, T.K.; Mitra, S. Early steps in the DNA base excision/single-strand 
interruption repair pathway in mammalian cells. Cell Res. 2008, 18, 27–47. 
24. Lyras, L.; Cairns, N.J.; Jenner, A.; Jenner, P.; Halliwell, B. An assessment of oxidative damage 
to proteins, lipids, and DNA in brain from patients with Alzheimer’s disease. J. Neurochem. 
1997, 68, 2061–2069. 
25. Halliwell, B. Antioxidant defence mechanisms: From the beginning to the end (of the beginning). 
Free Radic. Res. 1999, 31, 261–272. 
26. Tsuzuki, K.; Sugiyama, M.; Haramaki, N. DNA single-strand breaks and cytotoxicity induced  
by chromate(VI), cadmium(II), and mercury(II) in hydrogen peroxide-resistant cell lines.  
Environ. Health Perspect. 1994, 102, 341–342. 
27. Lai, H.; Singh, N.P. Magnetic-field-induced DNA strand breaks in brain cells of the rat.  
Environ. Health Perspect. 2004, 112, 687–694. 
28. Chen, Q.; Marsh, J.; Ames, B.; Mossman, B. Detection of 8-oxo-2'-deoxyguanosine, a marker of 
oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite 
asbestos. Carcinogenesis 1996, 17, 2525–2527. 
Biomolecules 2014, 4 693 
 
 
29. Radak, Z.; Boldogh, I. 8-oxo-7,8-dihydroguanine: Links to gene expression, aging, and defense 
against oxidative stress. Free Radic. Biol. Med. 2010, 49, 587–596. 
30. .Bourassa, M.W.; Leskovjan, A.C.; Tappero, R.V.; Farquhar, E.R.; Colton, C.A.; van Nostrand, W.E.; 
Miller, L.M. Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse 
models of Alzheimer’s disease that exhibit neurodegeneration. Biomed. Spectrosc. Imaging 2013, 
2, 129–139. 
31. Tiiman, A.; Palumaa, P.; Tougu, V. The missing link in the amyloid cascade of Alzheimer’s 
disease—Metal ions. Neurochem. Int. 2013, 62, 367–378. 
32. Lovell, M.A.; Robertson, J.D.; Teesdale, W.J.; Campbell, J.L.; Markesbery, W.R. Copper, iron 
and zinc in Alzheimer’s disease senile plaques. J. Neurol. Sci. 1998, 158, 47–52. 
33. Strong, M.J. Aluminum neurotoxicity: An experimental approach to the induction of 
neurofilamentous inclusions. J. Neurol. Sci. 1994, 124, 20–26. 
34. Zecca, L.; Youdim, M.B.; Riederer, P.; Connor, J.R.; Crichton, R.R. Iron, brain ageing and 
neurodegenerative disorders. Nat. Rev. Neurosci. 2004, 5, 863–873. 
35. Sofic, E.; Riederer, P.; Heinsen, H.; Beckmann, H.; Reynolds, G.P.; Hebenstreit, G.; Youdim, M.B. 
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.  
J. Neural. Transm. 1988, 74, 199–205. 
36. Schipper, H.M. Astrocytes, brain aging, and neurodegeneration. Neurobiol. Aging 1996, 17,  
467–480. 
37. Forte, G.; Bocca, B.; Senofonte, O.; Petrucci, F.; Brusa, L.; Stanzione, P.; Zannino, S.;  
Violante, N.; Alimonti, A.; Sancesario, G. Trace and major elements in whole blood, serum, 
cerebrospinal fluid and urine of patients with Parkinson’s disease. J. Neural. Transm. 2004, 111, 
1031–1040. 
38. Rasia, R.M.; Bertoncini, C.W.; Marsh, D.; Hoyer, W.; Cherny, D.; Zweckstetter, M.; Griesinger, C.; 
Jovin, T.M.; Fernandez, C.O. Structural characterization of copper(II) binding to alpha-synuclein: 
Insights into the bioinorganic chemistry of Parkinson’s disease. Proc. Natl. Acad. Sci. USA 2005, 
102, 4294–4299. 
39. Lucchini, R.G.; Martin, C.J.; Doney, B.C. From manganism to manganese-induced parkinsonism: 
A conceptual model based on the evolution of exposure. Neuromol. Med. 2009, 11, 311–321. 
40. Milatovic, D.; Zaja-Milatovic, S.; Gupta, R.C.; Yu, Y.; Aschner, M. Oxidative damage and 
neurodegeneration in manganese-induced neurotoxicity. Toxicol. Appl. Pharmacol. 2009, 240, 
219–225. 
41. Fox, J.H.; Kama, J.A.; Lieberman, G.; Chopra, R.; Dorsey, K.; Chopra, V.; Volitakis, I.;  
Cherny, R.A.; Bush, A.I.; Hersch, S. Mechanisms of copper ion mediated Huntington’s disease 
progression. PLoS One 2007, 2, e334. 
42. Xiao, B.G.; Link, H. Immune regulation within the central nervous system. J. Neurol. Sci. 1998, 
157, 1–12. 
43. Dexter, D.T.; Jenner, P.; Schapira, A.H.; Marsden, C.D. Alterations in levels of iron, ferritin, and 
other trace metals in neurodegenerative diseases affecting the basal ganglia. The royal kings and 
queens Parkinson’s disease research group. Ann. Neurol. 1992, 32, S94–S100. 
Biomolecules 2014, 4 694 
 
 
44. Boll, M.C.; Alcaraz-Zubeldia, M.; Montes, S.; Rios, C. Free copper, ferroxidase and SOD1 
activities, lipid peroxidation and NOx content in the CSF. A different marker profile in four 
neurodegenerative diseases. Neurochem. Res. 2008, 33, 1717–1723. 
45. Loeffler, D.A.; LeWitt, P.A.; Juneau, P.L.; Sima, A.A.; Nguyen, H.U.; DeMaggio, A.J.; 
Brickman, C.M.; Brewer, G.J.; Dick, R.D.; Troyer, M.D.; et al. Increased regional brain 
concentrations of ceruloplasmin in neurodegenerative disorders. Brain Res. 1996, 738, 265–274. 
46. Simmons, D.A.; Casale, M.; Alcon, B.; Pham, N.; Narayan, N.; Lynch, G. Ferritin accumulation 
in dystrophic microglia is an early event in the development of Huntington’s disease. Glia 2007, 
55, 1074–1084. 
47. Bartzokis, G.; Cummings, J.; Perlman, S.; Hance, D.B.; Mintz, J. Increased basal ganglia iron 
levels in Huntington disease. Arch. Neurol. 1999, 56, 569–574. 
48. Fatemi, N.; Sarkar, B. Molecular mechanism of copper transport in wilson disease.  
Environ. Health Perspect. 2002, 110, 695–698. 
49. Litwin, T.; Gromadzka, G.; Szpak, G.M.; Jablonka-Salach, K.; Bulska, E.; Czlonkowska, A. 
Brain metal accumulation in Wilson’s disease. J. Neurol. Sci. 2013, 329, 55–58. 
50. DiDonato, M.; Hsu, H.F.; Narindrasorasak, S.; Que, L., Jr.; Sarkar, B. Copper-induced 
conformational changes in the N-terminal domain of the Wilson disease copper-transporting ATPase. 
Biochemistry 2000, 39, 1890–1896. 
51. Kanwar, P.; Kowdley, K.V. Metal storage disorders: Wilson disease and hemochromatosis.  
Med. Clin. North Am. 2014, 98, 87–102. 
52. Jeong, S.Y.; Rathore, K.I.; Schulz, K.; Ponka, P.; Arosio, P.; David, S. Dysregulation of iron 
homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic 
lateral sclerosis. J. Neurosci. 2009, 29, 610–619. 
53. Kasarskis, E.J.; Tandon, L.; Lovell, M.A.; Ehmann, W.D. Aluminum, calcium, and iron in the 
spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass 
spectroscopy: A preliminary study. J. Neurol. Sci. 1995, 130, 203–208. 
54. Koeppen, A.H.; Ramirez, R.L.; Yu, D.; Collins, S.E.; Qian, J.; Parsons, P.J.; Yang, K.X.; Chen, Z.; 
Mazurkiewicz, J.E.; Feustel, P.J. Friedreich’s ataxia causes redistribution of iron, copper, and 
zinc in the dentate nucleus. Cerebellum 2012, 11, 845–860. 
55. Hu, K.H.; Friede, R.L. Topographic determination of zinc in human brain by atomic absorption 
spectrophotometry. J. Neurochem. 1968, 15, 677–685. 
56. Cossee, M.; Puccio, H.; Gansmuller, A.; Koutnikova, H.; Dierich, A.; LeMeur, M.; Fischbeck, K.; 
Dolle, P.; Koenig, M. Inactivation of the friedreich ataxia mouse gene leads to early embryonic 
lethality without iron accumulation. Hum. Mol. Genet. 2000, 9, 1219–1226. 
57. Kopera, E.; Schwerdtle, T.; Hartwig, A.; Bal, W. Co(II) and Cd(II) substitute for Zn(II) in the 
zinc finger derived from the DNA repair protein XPA, demonstrating a variety of potential 
mechanisms of toxicity. Chem. Res. Toxicol. 2004, 17, 1452–1458. 
58. Hartwig, A.; Schwerdtle, T.; Bal, W. Biophysical analysis of the interaction of toxic metal ions 
and oxidants with the zinc finger domain of XPA. Methods Mol. Biol. 2010, 649, 399–410. 
59. Bal, W.; Schwerdtle, T.; Hartwig, A. Mechanism of NICKEl assault on the zinc finger of DNA 
repair protein XPA. Chem. Res. Toxicol. 2003, 16, 242–248. 
Biomolecules 2014, 4 695 
 
 
60. Zhou, Z.; Wang, C.; Liu, H.; Huang, Q.; Wang, M.; Lei, Y. Cadmium induced cell apoptosis, 
DNA damage, decreased DNA repair capacity, and genomic instability during malignant 
transformation of human bronchial epithelial cells. Int. J. Med. Sci. 2013, 10, 1485–1496. 
61. Smith, E.B. Primary cancer of the lung in women. J. Natl. Med. Assoc. 1989, 81, 945–948. 
62. Lam, T.V.; Agovino, P.; Niu, X.; Roche, L. Linkage study of cancer risk among lead-exposed 
workers in new jersey. Sci. Total Environ. 2007, 372, 455–462. 
63. Beveridge, R.; Pintos, J.; Parent, M.E.; Asselin, J.; Siemiatycki, J. Lung cancer risk associated 
with occupational exposure to NICKEl, chromium VI, and cadmium in two population-based  
case-control studies in montreal. Am. J. Ind. Med. 2010, 53, 476–485. 
64. Koedrith, P.; Kim, H.; Weon, J.I.; Seo, Y.R. Toxicogenomic approaches for understanding 
molecular mechanisms of heavy metal mutagenicity and carcinogenicity. Int. J. Hyg. Environ. 
Health 2013, 216, 587–598. 
65. Aquino, N.B.; Sevigny, M.B.; Sabangan, J.; Louie, M.C. The role of cadmium and NICKEl in 
estrogen receptor signaling and breast cancer: Metalloestrogens or not? J. Environ. Sci. Health C 
2012, 30, 189–224. 
66. McCullough, A.K.; Dodson, M.L.; Lloyd, R.S. Initiation of base excision repair: Glycosylase 
mechanisms and structures. Annu. Rev. Biochem. 1999, 68, 255–285. 
67. Bandaru, V.; Sunkara, S.; Wallace, S.S.; Bond, J.P. A novel human DNA glycosylase that 
removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII.  
DNA Repair 2002, 1, 517–529. 
68. Hazra, T.K.; Izumi, T.; Boldogh, I.; Imhoff, B.; Kow, Y.W.; Jaruga, P.; Dizdaroglu, M.; Mitra, S. 
Identification and characterization of a human DNA glycosylase for repair of modified bases in 
oxidatively damaged DNA. Proc. Natl. Acad. Sci. USA 2002, 99, 3523–3528. 
69. Ellenberger, T.; Tomkinson, A.E. Eukaryotic DNA ligases: Structural and functional insights. 
Annu. Rev. Biochem. 2008, 77, 313–338. 
70. Prakash, A.; Doublie, S.; Wallace, S.S. The Fpg/Nei family of DNA glycosylases: Substrates, 
structures, and search for damage. Prog. Mol. Biol. Transl. Sci. 2012, 110, 71–91. 
71. Hazra, T.K.; Kow, Y.W.; Hatahet, Z.; Imhoff, B.; Boldogh, I.; Mokkapati, S.K.; Mitra, S.;  
Izumi, T. Identification and characterization of a novel human DNA glycosylase for repair of 
cytosine-derived lesions. J. Biol. Chem. 2002, 277, 30417–30420. 
72. Liu, M.; Bandaru, V.; Bond, J.P.; Jaruga, P.; Zhao, X.; Christov, P.P.; Burrows, C.J.; Rizzo, C.J.; 
Dizdaroglu, M.; Wallace, S.S. The mouse ortholog of NEIL3 is a functional DNA glycosylase  
in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2010, 107, 4925–4930. 
73. Wallace, S.S.; Bandaru, V.; Kathe, S.D.; Bond, J.P. The enigma of endonuclease VIII.  
DNA Repair 2003, 2, 441–453. 
74. Wallace, S.S. Base excision repair: A critical player in many games. DNA Repair 2014, 19, 14–26. 
75. Wiederhold, L.; Leppard, J.B.; Kedar, P.; Karimi-Busheri, F.; Rasouli-Nia, A.; Weinfeld, M.; 
Tomkinson, A.E.; Izumi, T.; Prasad, R.; Wilson, S.H.; et al. AP endonuclease-independent DNA 
base excision repair in human cells. Mol. Cell 2004, 15, 209–220. 
76. Sobol, R.W.; Prasad, R.; Evenski, A.; Baker, A.; Yang, X.P.; Horton, J.K.; Wilson, S.H. The 
lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced 
cytotoxicity. Nature 2000, 405, 807–810. 
Biomolecules 2014, 4 696 
 
 
77. Hegde, M.L.; Hegde, P.M.; Bellot, L.J.; Mandal, S.M.; Hazra, T.K.; Li, G.M.; Boldogh, I.; 
Tomkinson, A.E.; Mitra, S. Prereplicative repair of oxidized bases in the human genome is 
mediated by neil1 DNA glycosylase together with replication proteins. Proc. Natl. Acad. Sci. USA 
2013, 110, E3090–E3099. 
78. Hegde, M.L.; Theriot, C.A.; Das, A.; Hegde, P.M.; Guo, Z.; Gary, R.K.; Hazra, T.K.; Shen, B.; 
Mitra, S. Physical and functional interaction between human oxidized base-specific DNA 
glycosylase NEIL1 and flap endonuclease 1. J. Biol. Chem. 2008, 283, 27028–27037. 
79. Liu, Y.; Kao, H.I.; Bambara, R.A. Flap endonuclease 1: A central component of DNA metabolism. 
Annu. Rev. Biochem. 2004, 73, 589–615. 
80. Tomkinson, A.E.; Chen, L.; Dong, Z.; Leppard, J.B.; Levin, D.S.; Mackey, Z.B.; Motycka, T.A. 
Completion of base excision repair by mammalian DNA ligases. Prog. Nucleic Acid Res. Mol. Biol. 
2001, 68, 151–164. 
81. Simsek, D.; Furda, A.; Gao, Y.; Artus, J.; Brunet, E.; Hadjantonakis, A.K.; van Houten, B.; 
Shuman, S.; McKinnon, P.J.; Jasin, M. Crucial role for DNA ligase III in mitochondria but not in 
XRCC1-dependent repair. Nature 2011, 471, 245–248. 
82. Montecucco, A.; Biamonti, G.; Savini, E.; Focher, F.; Spadari, S.; Ciarrocchi, G. DNA ligase I gene 
expression during differentiation and cell proliferation. Nucleic Acids Res. 1992, 20, 6209–6214. 
83. Dou, H.; Theriot, C.A.; Das, A.; Hegde, M.L.; Matsumoto, Y.; Boldogh, I.; Hazra, T.K.;  
Bhakat, K.K.; Mitra, S. Interaction of the human DNA glycosylase NEIL1 with proliferating cell 
nuclear antigen. The potential for replication-associated repair of oxidized bases in mammalian 
genomes. J. Biol. Chem. 2008, 283, 3130–3140. 
84. Yang, S.W.; Burgin, A.B., Jr.; Huizenga, B.N.; Robertson, C.A.; Yao, K.C.; Nash, H.A.  
A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I 
topoisomerases. Proc. Natl. Acad. Sci. USA 1996, 93, 11534–11539. 
85. Pouliot, J.J.; Yao, K.C.; Robertson, C.A.; Nash, H.A. Yeast gene for a Tyr-DNA phosphodiesterase 
that repairs topoisomerase I complexes. Science 1999, 286, 552–555. 
86. El-Khamisy, S.F.; Saifi, G.M.; Weinfeld, M.; Johansson, F.; Helleday, T.; Lupski, J.R.; 
Caldecott, K.W. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal 
neuropathy-1. Nature 2005, 434, 108–113. 
87. Ahel, I.; Rass, U.; El-Khamisy, S.F.; Katyal, S.; Clements, P.M.; McKinnon, P.J.; Caldecott, K.W.; 
West, S.C. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation 
intermediates. Nature 2006, 443, 713–716. 
88. Rass, U.; Ahel, I.; West, S.C. Actions of aprataxin in multiple DNA repair pathways.  
J. Biol. Chem. 2007, 282, 9469–9474. 
89. Banerjee, D.; Mandal, S.M.; Das, A.; Hegde, M.L.; Das, S.; Bhakat, K.K.; Boldogh, I.;  
Sarkar, P.S.; Mitra, S.; Hazra, T.K. Preferential repair of oxidized base damage in the transcribed 
genes of mammalian cells. J. Biol. Chem. 2011, 286, 6006–6016. 
90. Schreiber, V.; Dantzer, F.; Ame, J.C.; de Murcia, G. Poly(ADP-ribose): Novel functions for an 
old molecule. Nat. Rev. Mol. Cell Biol. 2006, 7, 517–528. 
91. Caldecott, K.W. Single-strand break repair and genetic disease. Nat. Rev. Genet. 2008, 9, 619–631. 
Biomolecules 2014, 4 697 
 
 
92. Dianova, I.I.; Sleeth, K.M.; Allinson, S.L.; Parsons, J.L.; Breslin, C.; Caldecott, K.W.; Dianov, G.L. 
XRCC1-DNA polymerase beta interaction is required for efficient base excision repair.  
Nucleic Acids Res. 2004, 32, 2550–2555. 
93. El-Khamisy, S.F.; Hartsuiker, E.; Caldecott, K.W. TDP1 facilitates repair of ionizing  
radiation-induced DNA single-strand breaks. DNA Repair 2007, 6, 1485–1495. 
94. Vidal, A.E.; Boiteux, S.; Hickson, I.D.; Radicella, J.P. XRCC1 coordinates the initial and  
late stages of DNA abasic site repair through protein-protein interactions. EMBO J. 2001, 20, 
6530–6539. 
95. Chattopadhyay, R.; Das, S.; Maiti, A.K.; Boldogh, I.; Xie, J.; Hazra, T.K.; Kohno, K.; Mitra, S.; 
Bhakat, K.K. Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated 
activation of the multidrug resistance gene MDR1. Mol. Cell. Biol. 2008, 28, 7066–7080. 
96. Marenstein, D.R.; Ocampo, M.T.; Chan, M.K.; Altamirano, A.; Basu, A.K.; Boorstein, R.J.; 
Cunningham, R.P.; Teebor, G.W. Stimulation of human endonuclease III by Y box-binding 
protein 1 (DNA-binding protein β). Interaction between a base excision repair enzyme and  
a transcription factor. J. Biol. Chem. 2001, 276, 21242–21249. 
97. Hegde, M.L.; Banerjee, S.; Hegde, P.M.; Bellot, L.J.; Hazra, T.K.; Boldogh, I.; Mitra, S. 
Enhancement of NEIL1 protein-initiated oxidized DNA base excision repair by heterogeneous 
nuclear ribonucleoprotein U (hnRNP-U) via direct interaction. J. Biol. Chem. 2012, 287,  
34202–34211. 
98. Bhakat, K.K.; Hazra, T.K.; Mitra, S. Acetylation of the human DNA glycosylase NEIL2 and 
inhibition of its activity. Nucleic Acids Res. 2004, 32, 3033–3039. 
99. Bhakat, K.K.; Mokkapati, S.K.; Boldogh, I.; Hazra, T.K.; Mitra, S. Acetylation of human  
8-oxoguanine-DNA glycosylase by p300 and its role in 8-oxoguanine repair in vivo. Mol. Cell. Biol. 
2006, 26, 1654–1665. 
100. Sengupta, S.; Mantha, A.K.; Mitra, S.; Bhakat, K.K. Human AP endonuclease (APE1/Ref-1)  
and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the  
drug-induced activation of multidrug resistance gene MDR1. Oncogene 2010, 30, 482–493. 
101. Tini, M.; Benecke, A.; Um, S.J.; Torchia, J.; Evans, R.M.; Chambon, P. Association of 
CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription.  
Mol. Cell 2002, 9, 265–277. 
102. Yacoub, A.; Kelley, M.R.; Deutsch, W.A. The DNA repair activity of human redox/repair 
protein APE/Ref-1 is inactivated by phosphorylation. Cancer Res. 1997, 57, 5457–5459. 
103. Fritz, G.; Kaina, B. Phosphorylation of the DNA repair protein APE/Ref-1 by CKII affects redox 
regulation of AP-1. Oncogene 1999, 18, 1033–1040. 
104. Huang, E.; Qu, D.; Zhang, Y.; Venderova, K.; Haque, M.E.; Rousseaux, M.W.; Slack, R.S.; 
Woulfe, J.M.; Park, D.S. The role of CDK5-mediated apurinic/apyrimidinic endonuclease 1 
phosphorylation in neuronal death. Nat. Cell Biol. 2010, 12, 563–571. 
105. Parsons, J.L.; Tait, P.S.; Finch, D.; Dianova, I.I.; Edelmann, M.J.; Khoronenkova, S.V.; Kessler, B.M.; 
Sharma, R.A.; McKenna, W.G.; Dianov, G.L. Ubiquitin ligase ARF-BP1/mule modulates base 
excision repair. EMBO J. 2009, 28, 3207–3215. 
Biomolecules 2014, 4 698 
 
 
106. Parsons, J.L.; Dianova, I.I.; Finch, D.; Tait, P.S.; Strom, C.E.; Helleday, T.; Dianov, G.L. 
XRCC1 phosphorylation by CK2 is required for its stability and efficient DNA repair.  
DNA Repair 2010, 9, 835–841. 
107. Wang, T.; Simbulan-Rosenthal, C.M.; Smulson, M.E.; Chock, P.B.; Yang, D.C. Polyubiquitylation 
of PARP-1 through ubiquitin K48 is modulated by activated DNA, NAD
+
, and dipeptides.  
J. Cell. Biochem. 2008, 104, 318–328. 
108. Takahashi, H.; Hatakeyama, S.; Saitoh, H.; Nakayama, K.I. Noncovalent SUMO-1 binding 
activity of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and 
colocalization with the promyelocytic leukemia protein. J. Biol. Chem. 2005, 280, 5611–5621. 
109. Hardeland, U.; Steinacher, R.; Jiricny, J.; Schar, P. Modification of the human thymine-DNA 
glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J. 2002, 21, 1456–1464. 
110. Steinacher, R.; Schar, P. Functionality of human thymine DNA glycosylase requires  
SUMO-regulated changes in protein conformation. Curr. Biol. 2005, 15, 616–623. 
111. El-Andaloussi, N.; Valovka, T.; Toueille, M.; Hassa, P.O.; Gehrig, P.; Covic, M.; Hubscher, U.; 
Hottiger, M.O. Methylation of DNA polymerase beta by protein arginine methyltransferase 1 
regulates its binding to proliferating cell nuclear antigen. FASEB J. 2007, 21, 26–34. 
112. Kedar, P.S.; Kim, S.J.; Robertson, A.; Hou, E.; Prasad, R.; Horton, J.K.; Wilson, S.H. Direct 
interaction between mammalian DNA polymerase beta and proliferating cell nuclear antigen.  
J. Biol. Chem. 2002, 277, 31115–31123. 
113. Hakme, A.; Wong, H.K.; Dantzer, F.; Schreiber, V. The expanding field of poly(ADP-ribosyl)ation 
reactions. ―Protein modifications: Beyond the usual suspects‖ review series. EMBO Rep. 2008, 9, 
1094–1100. 
114. El-Khamisy, S.F.; Masutani, M.; Suzuki, H.; Caldecott, K.W. A requirement for PARP-1 for the 
assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 
2003, 31, 5526–5533. 
115. Huang, J.Y.; Chen, W.H.; Chang, Y.L.; Wang, H.T.; Chuang, W.T.; Lee, S.C. Modulation of 
nucleosome-binding activity of fact by poly(ADP-ribosyl)ation. Nucleic Acids Res. 2006, 34, 
2398–2407. 
116. Chang, D.Y.; Shi, G.; Durand-Dubief, M.; Ekwall, K.; Lu, A.L. The role of MutY homolog (Myh1) 
in controlling the histone deacetylase Hst4 in the fission yeast Schizosaccharomyces pombe.  
J. Mol. Biol. 2011, 405, 653–665. 
117. Hegde, M.L.; Izumi, T.; Mitra, S. Oxidized base damage and single-strand break repair in 
mammalian genomes: Role of disordered regions and posttranslational modifications in early 
enzymes. Prog. Mol. Biol. Transl. Sci. 2012, 110, 123–153. 
118. Hegde, M.L.; Hazra, T.K.; Mitra, S. Functions of disordered regions in mammalian early base 
excision repair proteins. Cell. Mol. Life Sci. 2010, 67, 3573–3587. 
119. Haynes, C.; Oldfield, C.J.; Ji, F.; Klitgord, N.; Cusick, M.E.; Radivojac, P.; Uversky, V.N.; 
Vidal, M.; Iakoucheva, L.M. Intrinsic disorder is a common feature of hub proteins from four 
eukaryotic interactomes. PLoS Comput. Biol. 2006, 2, e100. 
120. Pesole, G.; Gissi, C.; de Chirico, A.; Saccone, C. Nucleotide substitution rate of mammalian 
mitochondrial genomes. J. Mol. Evol. 1999, 48, 427–434. 
Biomolecules 2014, 4 699 
 
 
121. Yakes, F.M.; van Houten, B. Mitochondrial DNA damage is more extensive and persists longer 
than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 
1997, 94, 514–519. 
122. Caldecott, K.W.; McKeown, C.K.; Tucker, J.D.; Ljungquist, S.; Thompson, L.H. An interaction 
between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol. Cell. Biol. 1994, 
14, 68–76. 
123. Szczesny, B.; Tann, A.W.; Longley, M.J.; Copeland, W.C.; Mitra, S. Long patch base excision 
repair in mammalian mitochondrial genomes. J. Biol. Chem. 2008, 283, 26349–26356. 
124. Wunderlich, V.; Tetzlaff, I.; Graffi, A. Studies on nitrosodimethylamine: Preferential methylation 
of mitochondrial DNA in rats and hamsters. Chem. Biol. Interact. 1972, 4, 81–89. 
125. Gavin, C.E.; Gunter, K.K.; Gunter, T.E. Mn2+ sequestration by mitochondria and inhibition of 
oxidative phosphorylation. Toxicol. Appl. Pharmacol. 1992, 115, 1–5. 
126. Johnson, F.O.; Atchison, W.D. The role of environmental mercury, lead and pesticide exposure 
in development of amyotrophic lateral sclerosis. Neurotoxicology 2009, 30, 761–765. 
127. Sokolova, I.M.; Ringwood, A.H.; Johnson, C. Tissue-specific accumulation of cadmium in 
subcellular compartments of eastern oysters Crassostrea virginica Gmelin (Bivalvia: Ostreidae). 
Aquat. Toxicol. 2005, 74, 218–228. 
128. Karahalil, B.; Hogue, B.A.; de Souza-Pinto, N.C.; Bohr, V.A. Base excision repair capacity in 
mitochondria and nuclei: Tissue-specific variations. FASEB J. 2002, 16, 1895–1902. 
129. Szczesny, B.; Tann, A.W.; Mitra, S. Age- and tissue-specific changes in mitochondrial and nuclear 
DNA base excision repair activity in mice: Susceptibility of skeletal muscles to oxidative injury. 
Mech. Ageing Dev. 2010, 131, 330–337. 
130. Englander, E.W. Brain capacity for repair of oxidatively damaged DNA and preservation of 
neuronal function. Mech. Ageing Dev. 2008, 129, 475–482. 
131. Raffoul, J.J.; Cabelof, D.C.; Nakamura, J.; Meira, L.B.; Friedberg, E.C.; Heydari, A.R. 
Apurinic/apyrimidinic endonuclease (APE/Ref-1) haploinsufficient mice display tissue-specific 
differences in DNA polymerase beta-dependent base excision repair. J. Biol. Chem. 2004, 279, 
18425–18433. 
132. Canugovi, C.; Yoon, J.S.; Feldman, N.H.; Croteau, D.L.; Mattson, M.P.; Bohr, V.A. 
Endonuclease VIII-like 1 (NEIL1) promotes short-term spatial memory retention and protects 
from ischemic stroke-induced brain dysfunction and death in mice. Proc. Natl. Acad. Sci. USA 
2012, 109, 14948–14953. 
133. Torisu, K.; Tsuchimoto, D.; Ohnishi, Y.; Nakabeppu, Y. Hematopoietic tissue-specific expression 
of mouse NEIL3 for endonuclease VIII-like protein. J. Biochem. 2005, 138, 763–772. 
134. Hildrestrand, G.A.; Neurauter, C.G.; Diep, D.B.; Castellanos, C.G.; Krauss, S.; Bjoras, M.; Luna, L. 
Expression patterns of NEIL3 during embryonic brain development and neoplasia. BMC Neurosci. 
2009, doi:10.1186/1471-2202-10-45. 
135. Regnell, C.E.; Hildrestrand, G.A.; Sejersted, Y.; Medin, T.; Moldestad, O.; Rolseth, V.; 
Krokeide, S.Z.; Suganthan, R.; Luna, L.; Bjoras, M.; et al. Hippocampal adult neurogenesis is 
maintained by NEIL3-dependent repair of oxidative DNA lesions in neural progenitor cells.  
Cell Rep. 2012, 2, 503–510. 
Biomolecules 2014, 4 700 
 
 
136. Rolseth, V.; Krokeide, S.Z.; Kunke, D.; Neurauter, C.G.; Suganthan, R.; Sejersted, Y.; 
Hildrestrand, G.A.; Bjoras, M.; Luna, L. Loss of NEIL3, the major DNA glycosylase activity for 
removal of hydantoins in single stranded DNA, reduces cellular proliferation and sensitizes cells 
to genotoxic stress. Biochim. Biophys. Acta 2013, 1833, 1157–1164. 
137. Uhlen, M.; Oksvold, P.; Fagerberg, L.; Lundberg, E.; Jonasson, K.; Forsberg, M.; Zwahlen, M.; 
Kampf, C.; Wester, K.; Hober, S.; et al. Towards a knowledge-based human protein atlas.  
Nat. Biotechnol. 2010, 28, 1248–1250. 
138. Swain, U.; Subba Rao, K. Study of DNA damage via the comet assay and base excision  
repair activities in rat brain neurons and astrocytes during aging. Mech. Ageing Dev. 2011, 132, 
374–381. 
139. Fukae, J.; Mizuno, Y.; Hattori, N. Mitochondrial dysfunction in Parkinson’s disease. Mitochondrion 
2007, 7, 58–62. 
140. Sheng, Z.; Oka, S.; Tsuchimoto, D.; Abolhassani, N.; Nomaru, H.; Sakumi, K.; Yamada, H.; 
Nakabeppu, Y. 8-oxoguanine causes neurodegeneration during mutyh-mediated DNA base 
excision repair. J. Clin. Investig. 2012, 122, 4344–4361. 
141. Jiang, Y.; Guo, C.; Fishel, M.L.; Wang, Z.Y.; Vasko, M.R.; Kelley, M.R. Role of APE1 in 
differentiated neuroblastoma SH-SY5Y cells in response to oxidative stress: Use of APE1 small 
molecule inhibitors to delineate APE1 functions. DNA Repair 2009, 8, 1273–1282. 
142. Vasko, M.R.; Guo, C.; Kelley, M.R. The multifunctional DNA repair/redox enzyme APE1/Ref-1 
promotes survival of neurons after oxidative stress. DNA Repair 2005, 4, 367–379. 
143. Jiang, Y.; Guo, C.; Vasko, M.R.; Kelley, M.R. Implications of apurinic/apyrimidinic endonuclease 
in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. 
Cancer Res. 2008, 68, 6425–6434. 
144. Breslin, C.; Caldecott, K.W. DNA 3'-phosphatase activity is critical for rapid global rates of 
single-strand break repair following oxidative stress. Mol. Cell. Biol. 2009, 29, 4653–4662. 
145. Wilson, S.H. Mammalian base excision repair and DNA polymerase beta. Mutat. Res. 1998, 407, 
203–215. 
146. Wilson, D.M., 3rd; McNeill, D.R. Base excision repair and the central nervous system. 
Neuroscience 2007, 145, 1187–1200. 
147. Akbari, M.; Pena-Diaz, J.; Andersen, S.; Liabakk, N.B.; Otterlei, M.; Krokan, H.E. Extracts of 
proliferating and non-proliferating human cells display different base excision pathways and 
repair fidelity. DNA Repair 2009, 8, 834–843. 
148. Wei, W.; Englander, E.W. DNA polymerase beta-catalyzed-PCNA independent long patch  
base excision repair synthesis: A mechanism for repair of oxidatively damaged DNA ends in 
post-mitotic brain. J. Neurochem. 2008, 107, 734–744. 
149. Kenche, V.B.; Barnham, K.J. Alzheimer’s disease & metals: Therapeutic opportunities.  
Br. J. Pharmacol. 2011, 163, 211–219. 
150. Raven, E.P.; Lu, P.H.; Tishler, T.A.; Heydari, P.; Bartzokis, G. Increased iron levels and 
decreased tissue integrity in hippocampus of Alzheimer’s disease detected in vivo with magnetic 
resonance imaging. J. Alzheimers Dis. 2013, 37, 127–136. 
Biomolecules 2014, 4 701 
 
 
151. Lee, H.P.; Zhu, X.; Liu, G.; Chen, S.G.; Perry, G.; Smith, M.A.; Lee, H.G. Divalent  
metal transporter, iron, and Parkinson’s disease: A pathological relationship. Cell Res. 2010, 20,  
397–399. 
152. Pamphlett, R.; Kum Jew, S. Heavy metals in locus ceruleus and motor neurons in motor neuron 
disease. Acta Neuropathol. Commun. 2013, doi:10.1186/2051-5960-1-81. 
153. Barbeito, A.G.; Levade, T.; Delisle, M.B.; Ghetti, B.; Vidal, R. Abnormal iron metabolism  
in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.  
Mol. Neurodegener. 2010, doi:10.1186/1750-1326-5-50. 
154. Texel, S.J.; Xu, X.; Harris, Z.L. Ceruloplasmin in neurodegenerative diseases. Biochem. Soc. Trans. 
2008, 36, 1277–1281. 
155. Koeppen, A.H. A brief history of brain iron research. J. Neurol. Sci. 2003, 207, 95–97. 
156. Rao, G.N.; Ney, E.; Herbert, R.A. Changes associated with delay of mammary cancer by  
retinoid analogues in transgenic mice bearing c-neu oncogene. Breast Cancer Res. Treat. 1999, 
58, 241–254. 
157. Molina-Holgado, F.; Hider, R.C.; Gaeta, A.; Williams, R.; Francis, P. Metals ions and 
neurodegeneration. Biometals 2007, 20, 639–654. 
158. Huang, X.; Atwood, C.S.; Moir, R.D.; Hartshorn, M.A.; Vonsattel, J.P.; Tanzi, R.E.; Bush, A.I. 
Zinc-induced Alzheimer’s Abeta1-40 aggregation is mediated by conformational factors.  
J. Biol. Chem. 1997, 272, 26464–26470. 
159. Youdim, M.B.; Ben-Shachar, D.; Riederer, P. Iron in brain function and dysfunction with 
emphasis on Parkinson’s disease. Eur. Neurol. 1991, 31, 34–40. 
160. Bowman, A.B.; Kwakye, G.F.; Herrero Hernandez, E.; Aschner, M. Role of manganese in 
neurodegenerative diseases. J. Trace Elem. Med. Biol. 2011, 25, 191–203. 
161. Shaw, C.A.; Tomljenovic, L. Aluminum in the central nervous system (CNS): Toxicity in 
humans and animals, vaccine adjuvants, and autoimmunity. Immunol. Res. 2013, 56, 304–316. 
162. Walton, N.M.; Shin, R.; Tajinda, K.; Heusner, C.L.; Kogan, J.H.; Miyake, S.; Chen, Q.; Tamura, K.; 
Matsumoto, M. Adult neurogenesis transiently generates oxidative stress. PLoS One 2012,  
7, e35264. 
163. Zatta, P. Biological models for the study of aluminum neurotoxicity. Acta Med. Romana 1997, 
35, 592–600. 
164. Rao, K.S.; Hegde, M.L.; Anitha, S.; Musicco, M.; Zucca, F.A.; Turro, N.J.; Zecca, L. Amyloid 
beta and neuromelanin—Toxic or protective molecules? The cellular context makes the difference. 
Prog. Neurobiol. 2006, 78, 364–373. 
165. Wright, R.O.; Tsaih, S.W.; Schwartz, J.; Spiro, A., 3rd; McDonald, K.; Weiss, S.T.; Hu, H.  
Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 2003, 
14, 713–718. 
166. Tavakoli-Nezhad, M.; Barron, A.J.; Pitts, D.K. Postnatal inorganic lead exposure decreases the 
number of spontaneously active midbrain dopamine neurons in the rat. Neurotoxicology 2001, 
22, 259–269. 
167. Basha, M.R.; Murali, M.; Siddiqi, H.K.; Ghosal, K.; Siddiqi, O.K.; Lashuel, H.A.; Ge, Y.W.; 
Lahiri, D.K.; Zawia, N.H. Lead (PB) exposure and its effect on APP proteolysis and Abeta 
aggregation. FASEB J. 2005, 19, 2083–2084. 
Biomolecules 2014, 4 702 
 
 
168. Wu, J.; Basha, M.R.; Brock, B.; Cox, D.P.; Cardozo-Pelaez, F.; McPherson, C.A.; Harry, J.; 
Rice, D.C.; Maloney, B.; Chen, D.; et al. Alzheimer’s disease (AD)-like pathology in aged 
monkeys after infantile exposure to environmental metal lead (PB): Evidence for a developmental 
origin and environmental link for AD. J. Neurosci. 2008, 28, 3–9. 
169. Bourdineaud, J.P.; Fujimura, M.; Laclau, M.; Sawada, M.; Yasutake, A. Deleterious effects in 
mice of fish-associated methylmercury contained in a diet mimicking the western populations’ 
average fish consumption. Environ. Int. 2011, 37, 303–313. 
170. Yee, S.; Choi, B.H. Oxidative stress in neurotoxic effects of methylmercury poisoning. 
Neurotoxicology 1996, 17, 17–26. 
171. Hegde, M.L.; Anitha, S.; Latha, K.S.; Mustak, M.S.; Stein, R.; Ravid, R.; Rao, K.S. First 
evidence for helical transitions in supercoiled DNA by amyloid beta peptide (1–42) and 
aluminum: A new insight in understanding Alzheimer’s disease. J. Mol. Neurosci. 2004, 22, 19–31. 
172. Rao, K.S.J.; Rao, R.V.; Shanmugavelu, P.; Menon, R.B. Trace elements in Alzheimer’s disease 
brain: A new hypothesis. Alzheimers Rep. 1999, 2, 241–246. 
173. Pande, M.B.; Nagabhushan, P.; Hegde, M.L.; Rao, T.S.; Rao, K.S. An algorithmic approach  
to understand trace elemental homeostasis in serum samples of parkinson disease.  
Comput. Biol. Med. 2005, 35, 475–493. 
174. Pfaender, S.; Grabrucker, A.M. Characterization of biometal profiles in neurological disorders. 
Metallomics 2014, 6, 960–977. 
175. Hegde, M.L.; Hegde, P.M.; Rao, K.S.; Mitra, S. Oxidative genome damage and its repair in 
neurodegenerative diseases: Function of transition metals as a double-edged sword. J. Alzheimers Dis. 
2011, 24, 183–198. 
176. Robison, S.H.; Cantoni, O.; Costa, M. Analysis of metal-induced DNA lesions and DNA-repair 
replication in mammalian cells. Mutat. Res. 1984, 131, 173–181. 
177. Giles, N.M.; Watts, A.B.; Giles, G.I.; Fry, F.H.; Littlechild, J.A.; Jacob, C. Metal and redox 
modulation of cysteine protein function. Chem. Biol. 2003, 10, 677–693. 
178. Himmelfarb, J.; McMonagle, E.; McMenamin, E. Plasma protein thiol oxidation and carbonyl 
formation in chronic renal failure. Kidney Int. 2000, 58, 2571–2578. 
179. Hegde, M.L.; Gupta, V.B.; Anitha, M.; Harikrishna, T.; Shankar, S.K.; Muthane, U.; Subba Rao, K.; 
Jagannatha Rao, K.S. Studies on genomic DNA topology and stability in brain regions of 
Parkinson’s disease. Arch. Biochem. Biophys. 2006, 449, 143–156. 
180. Jeppesen, D.K.; Bohr, V.A.; Stevnsner, T. DNA repair deficiency in neurodegeneration.  
Prog. Neurobiol. 2011, 94, 166–200. 
181. Rass, U.; Ahel, I.; West, S.C. Defective DNA repair and neurodegenerative disease. Cell 2007, 
130, 991–1004. 
182. Maynard, S.; Schurman, S.H.; Harboe, C.; de Souza-Pinto, N.C.; Bohr, V.A. Base excision repair 
of oxidative DNA damage and association with cancer and aging. Carcinogenesis 2009, 30, 2–10. 
183. Gredilla, R.; Garm, C.; Stevnsner, T. Nuclear and mitochondrial DNA repair in selected 
eukaryotic aging model systems. Oxid. Med. Cell. Longev. 2012, doi:10.1155/2012/282438. 
184. Hartwig, A. Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity:  
A review. Environ. Health Perspect. 1994, 102, 45–50. 
Biomolecules 2014, 4 703 
 
 
185. Hengstler, J.G.; Bolm-Audorff, U.; Faldum, A.; Janssen, K.; Reifenrath, M.; Gotte, W.; Jung, D.; 
Mayer-Popken, O.; Fuchs, J.; Gebhard, S.; et al. Occupational exposure to heavy metals: DNA 
damage induction and DNA repair inhibition prove co-exposures to cadmium, cobalt and lead as 
more dangerous than hitherto expected. Carcinogenesis 2003, 24, 63–73. 
186. Adhikari, S.; Toretsky, J.A.; Yuan, L.; Roy, R. Magnesium, essential for base excision repair 
enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase. J. Biol. Chem. 2006, 
281, 29525–29532. 
187. Wang, P.; Guliaev, A.B.; Hang, B. Metal inhibition of human n-methylpurine-DNA glycosylase 
activity in base excision repair. Toxicol. Lett. 2006, 166, 237–247. 
188. Whiteside, J.R.; Box, C.L.; McMillan, T.J.; Allinson, S.L. Cadmium and copper inhibit both 
DNA repair activities of polynucleotide kinase. DNA Repair 2010, 9, 83–89. 
189. McNeill, D.R.; Narayana, A.; Wong, H.K.; Wilson, D.M., 3rd. Inhibition of APE1 nuclease 
activity by lead, iron, and cadmium. Environ. Health Perspect. 2004, 112, 799–804. 
190. Hegde, M.L.; Jagannatha Rao, K.S. Challenges and complexities of alpha-synuclein toxicity: New 
postulates in unfolding the mystery associated with Parkinson’s disease. Arch. Biochem. Biophys. 
2003, 418, 169–178. 
191. Hegde, M.L. Molecular characterization of neuroprotective activities of plant based products 
could revive their utilization and lead discovery of new drug candidates for brain diseases.  
J. Pharm. Bioallied Sci. 2014, 6, 63–64. 
192. Romero, A.; Ramos, E.; de Los Rios, C.; Egea, J.; del Pino, J.; Reiter, R.J. A review of  
metal-catalyzed molecular damage: Protection by melatonin. J. Pineal Res. 2014, 56, 343–370. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
